Clinical Trial Update: Treatment of the Dumping Syndrome With Lanreotide Autogel® [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating lanreotide Autogel for the treatment of Dumping Syndrome, with status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dumping Syndrome

Drugs mentioned

• Lanreotide Autogel (lanreotide)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Dumping Syndrome | Phase 4 | Status: UNKNOWN